James G Kahn

Summary

Publications

  1. ncbi Cost-effectiveness of antiretroviral therapy for prevention
    James G Kahn
    University of California, San Francisco, USA
    Curr HIV Res 9:405-15. 2011
  2. ncbi Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness
    James G Kahn
    Philip R Lee Institute for Health Policy Studies, University of California, San Francisco, California, United States of America
    PLoS ONE 7:e31316. 2012
  3. ncbi Gestational diabetes mellitus: results from a survey of country prevalence and practices
    Aliya Jiwani
    Health Strategies International, San Francisco, USA
    J Matern Fetal Neonatal Med 25:600-10. 2012
  4. ncbi HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries
    Elliot Marseille
    Institute of Health Policy Studies, University of California, San Francisco, USA
    BMC Health Serv Res 7:108. 2007
  5. ncbi CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
    James G Kahn
    Philip R Lee Institute for Health Policy Studies and Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
    BMJ 343:d6884. 2011

Detail Information

Publications5

  1. ncbi Cost-effectiveness of antiretroviral therapy for prevention
    James G Kahn
    University of California, San Francisco, USA
    Curr HIV Res 9:405-15. 2011
    ..We end with a discussion of future directions for programmatic demonstrations and evaluation...
  2. ncbi Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness
    James G Kahn
    Philip R Lee Institute for Health Policy Studies, University of California, San Francisco, California, United States of America
    PLoS ONE 7:e31316. 2012
    ..We modeled the potential cost-effectiveness of a scaled-up integrated prevention campaign...
  3. ncbi Gestational diabetes mellitus: results from a survey of country prevalence and practices
    Aliya Jiwani
    Health Strategies International, San Francisco, USA
    J Matern Fetal Neonatal Med 25:600-10. 2012
    ..However, the global burden of GDM and the existing responses are not fully understood. We aimed to assess country prevalence and to summarize practices related to GDM screening and management...
  4. ncbi HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries
    Elliot Marseille
    Institute of Health Policy Studies, University of California, San Francisco, USA
    BMC Health Serv Res 7:108. 2007
    ..Information on the relationship between scale and unit costs is critical to project the cost of global HIV prevention efforts and to allocate prevention resources efficiently...
  5. ncbi CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
    James G Kahn
    Philip R Lee Institute for Health Policy Studies and Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA
    BMJ 343:d6884. 2011
    ..To examine the cost and cost effectiveness of quarterly CD4 cell count and viral load monitoring among patients taking antiretroviral therapy (ART)...